CS240973B2 - Production method of benzamide derivatives - Google Patents

Production method of benzamide derivatives Download PDF

Info

Publication number
CS240973B2
CS240973B2 CS836124A CS612483A CS240973B2 CS 240973 B2 CS240973 B2 CS 240973B2 CS 836124 A CS836124 A CS 836124A CS 612483 A CS612483 A CS 612483A CS 240973 B2 CS240973 B2 CS 240973B2
Authority
CS
Czechoslovakia
Prior art keywords
benzamide
imidazol
ylpropyl
amino
white solid
Prior art date
Application number
CS836124A
Other languages
Czech (cs)
English (en)
Other versions
CS612483A2 (en
Inventor
Michael J Aston
David Ch Cook
Colin J Daniels
Antony H Loveless
Jeremy D Pratt
Bernard T Bull
Original Assignee
May & Baker Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by May & Baker Ltd filed Critical May & Baker Ltd
Publication of CS612483A2 publication Critical patent/CS612483A2/cs
Publication of CS240973B2 publication Critical patent/CS240973B2/cs

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • C07D233/61—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms with hydrocarbon radicals, substituted by nitrogen atoms not forming part of a nitro radical, attached to ring nitrogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Diabetes (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Cardiology (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
CS836124A 1982-08-24 1983-08-22 Production method of benzamide derivatives CS240973B2 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB8224296 1982-08-24

Publications (2)

Publication Number Publication Date
CS612483A2 CS612483A2 (en) 1985-06-13
CS240973B2 true CS240973B2 (en) 1986-03-13

Family

ID=10532494

Family Applications (1)

Application Number Title Priority Date Filing Date
CS836124A CS240973B2 (en) 1982-08-24 1983-08-22 Production method of benzamide derivatives

Country Status (23)

Country Link
US (1) US4507315A (de)
JP (1) JPS5955873A (de)
KR (1) KR840005717A (de)
AT (1) ATA301083A (de)
AU (1) AU1818083A (de)
BE (1) BE897580A (de)
CA (1) CA1195993A (de)
CS (1) CS240973B2 (de)
DE (1) DE3330403A1 (de)
DK (1) DK386783A (de)
ES (2) ES525099A0 (de)
FI (1) FI832989A (de)
FR (1) FR2532310B1 (de)
GB (1) GB2126225B (de)
GR (1) GR78673B (de)
IL (1) IL69544A0 (de)
IT (1) IT1169775B (de)
LU (1) LU84974A1 (de)
NL (1) NL8302947A (de)
NO (1) NO833024L (de)
PT (1) PT77219B (de)
SE (1) SE8304545L (de)
ZA (1) ZA836191B (de)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0625144B2 (ja) * 1986-02-24 1994-04-06 四国化成工業株式会社 新規イミダゾール化合物及び該化合物の合成方法
US4916145A (en) * 1987-07-10 1990-04-10 Hoffmann-La Roche Inc. Substituted n-[(pyridyl)alkyl]aryl-carboxamide
US4886629A (en) * 1988-06-06 1989-12-12 Allied-Signal Inc. Process for the preparation of fluorinated benzene sulfonyl fluorides
CA2057324A1 (en) * 1990-12-18 1992-06-19 Lora Louise Fitch Benzamide and sulfonamide hypoglycemic agents
US6503935B1 (en) 1998-08-07 2003-01-07 Abbott Laboratories Imidazoles and related compounds as α1A agonists
EP1196385A1 (de) * 1999-07-06 2002-04-17 Vertex Pharmaceuticals Incorporated Beta-aminosäure derivate zur behandlung von neurologischen krankheiten
DE10121003A1 (de) * 2001-04-28 2002-12-19 Aventis Pharma Gmbh Anthranilsäureamide, Verfahren zur Herstellung, ihrer Verwendung als Medikament sowie sie enthaltende pharmazeutische Zubereitungen
US7297816B2 (en) 2004-09-24 2007-11-20 Janssen Pharmaceutica N.V. Sulfonamide compounds

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3349124A (en) * 1957-05-20 1967-10-24 Pfizer & Co C Oral antidiabetic agent
BE756062A (fr) * 1969-09-11 1971-03-11 Boehringer Sohn Ingelheim Derives de 1,1,1-trichlorethane leurs procedes de fabrication et leur utilisation en tant que substances biocides
DE2500157C2 (de) * 1975-01-03 1983-09-15 Hoechst Ag, 6230 Frankfurt N-Acyl-4-(2-aminoäthyl)-benzoesäuren, deren Salze und Ester, Verfahren zu deren Herstellung und deren Verwendung
DK148576A (da) * 1975-04-18 1976-10-19 Boehringer Mannheim Gmbh Fenylalkankarbonsyrederivater og fremgangsmade til deres fremstilling
DE2517229A1 (de) * 1975-04-18 1976-10-28 Boehringer Mannheim Gmbh Phenylalkylcarbonsaeure-derivate und verfahren zu ihrer herstellung
US4317915A (en) * 1976-08-23 1982-03-02 Hoffmann-La Roche Inc. Novel thiophene derivatives
NZ186175A (en) * 1977-01-27 1980-03-05 Shionogi & Co Meta-sulphonamidobenzamide derivatives
US4245120A (en) * 1977-09-27 1981-01-13 American Cyanamid Company 4-(Monoalkylamino)benzene polycarboxylic acids
LU79008A1 (de) * 1978-02-03 1979-09-06 Byk Gulden Lomberg Chem Fab W-(n-alkyl-n-benzoyl-amino)-phenylalkansaeuren,ihre verwendung und herstellung sowie sie enthaltende arzneimittel

Also Published As

Publication number Publication date
FI832989A0 (fi) 1983-08-22
ZA836191B (en) 1984-04-25
GB8322539D0 (en) 1983-09-21
FI832989A (fi) 1984-02-25
IT8322629A0 (it) 1983-08-24
BE897580A (fr) 1984-02-23
GB2126225A (en) 1984-03-21
CA1195993A (en) 1985-10-29
GR78673B (de) 1984-09-27
ES8505935A1 (es) 1985-06-16
IT1169775B (it) 1987-06-03
NL8302947A (nl) 1984-03-16
LU84974A1 (fr) 1984-03-23
FR2532310B1 (fr) 1986-01-10
ES528012A0 (es) 1985-06-16
NO833024L (no) 1984-02-24
DK386783A (da) 1984-02-25
PT77219A (fr) 1983-09-01
SE8304545D0 (sv) 1983-08-22
FR2532310A1 (fr) 1984-03-02
ES8502691A1 (es) 1985-01-16
AU1818083A (en) 1984-03-01
US4507315A (en) 1985-03-26
DK386783D0 (da) 1983-08-23
ATA301083A (de) 1985-11-15
ES525099A0 (es) 1985-01-16
KR840005717A (ko) 1984-11-16
JPS5955873A (ja) 1984-03-31
PT77219B (fr) 1986-02-04
CS612483A2 (en) 1985-06-13
IL69544A0 (en) 1983-11-30
SE8304545L (sv) 1984-02-25
GB2126225B (en) 1985-10-09
DE3330403A1 (de) 1984-03-01

Similar Documents

Publication Publication Date Title
KR100388747B1 (ko) 인돌유도체
FR2677984A1 (fr) Derives d'imidazoline n-substitues, leur preparation, les compositions pharmaceutiques en contenant.
EA009051B1 (ru) О-замещенные гидроксиарильные производные
CS262448B2 (en) Process for preparing derivatives of n-/2-aminophenyl/-benzamide
EP0288973A2 (de) Benzothiazolinon-Derivate, ihre Herstellung und pharmazeutische Zusammensetzung
FR2673427A1 (fr) Derives heterocycliques diazotes n-substitues par un groupement biphenylmethyle, leur preparation, les compositions pharmaceutiques en contenant.
CS240973B2 (en) Production method of benzamide derivatives
US5120749A (en) Platelet activating antagonists
US4691018A (en) Pyridine derivatives and their use as anti-allergic agents
FI89267C (fi) Foerfarande foer framstaellning av terapeutiskt aktiva 4,5-dihydro-oxazoler
CA1103245A (en) Process for the manufacture of novel oxadiazolopyrimidine derivatives
FI76076C (fi) Foerfarande foer framstaellning av farmakologiskt vaerdefulla heterocykliska foereningar.
EP0816338B1 (de) 3-(bis-substituierte-phenylmethylen)oxindol-derivate
EP0252727A1 (de) Aminosäure-Derivate
CA1277669C (en) Guanidinobenzoic ester derivative
US5037830A (en) Novel thiouracyl derivatives, pharmaceutical compositions containing them and process for preparing same
EP1748994B1 (de) Nitrooxyderivate von blutdrucksenkenden arzneimitteln
SK163895A3 (en) Derivatives of 1-oxo-2-(phenylsulfonylamino)pentyl-piperidine, preparation method thereof and pharmaceutical composition containing them
US4189480A (en) Isoquinoline derivatives
US5686452A (en) Indane derivative and processes for preparing the same
WO1994003450A1 (en) Furylthiazole and their use as h2-receptor antagonists and antimicrobial agents
EP0126894B1 (de) Troponon-Derivate, Verfahren zu deren Herstellung und diese enthaltende pharmazeutische Zusammensetzung
US4755523A (en) Abietamide derivatives
EP0682023B1 (de) Imidazopyridin-Derivate und Verfahren zu ihrer Herstellung
EP0145304B1 (de) Tetrahydro-beta-carbolinderivate und Verfahren zu ihrer Herstellung